comprehensive -WSS

comprehensive

author：explore 2025-09-06 05:03:30 - browse：65424

The human gut teems with bacteria and other colorful microbes. — NIH

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “twilight of immunity.” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

One theory is that it all starts in the bone marrow, where a primitive reserve of stem cells replenishes the ranks of blood and immune cells to the tune of about 500 billion new cells every day. Some of these hematopoietic stem cells, or HSCs, are more likely to become long-lived stewards of immune memory like B cells and T cells; others are more likely to give rise to blood cells and front-line immune defenders. They all work in concert to get the balance right. As people age, though, one lineage of HSCs starts to dominate, throwing the equilibrium off-kilter.

On Wednesday, a team of scientists at Stanford University and the National Institutes of Health Rocky Mountain Laboratories reported in Nature that this age-associated imbalance in HSCs is to blame for a cascade of downstream declines in immune function. And by restoring a youthful balance of these cells with injections of antibodies, they were able to rejuvenate the immune systems of older mice — enabling them to better fend off viral attacks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Vertex Pharmaceuticals may move headquarters in Boston

WSS

Mass General Brigham physicians react to latest merger step

Study: Black kids more likely to die after surgery than white kids

Young boy dies in trial for Pfizer Duchenne gene therapy

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Decaf coffee targeted by food safety group under obscure FDA rule

Hundreds died while taking an arthritis drug, but nobody alerted patients

explore

comprehensive

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Trial using CRISPR to edit HIV out of cells disappoints

Affirmative action in medical school literally saved lives

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Peter Hotez and the public health issue of online harassment

Will generative AI in health care meet the fate of IBM's Dr. Watson?

How to save PrEP access — and even expand it

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Donor acceptance rates hint at racial, gender bias in heart transplants: study

hotspot

Primary care physicians play key roles in Alzheimer's management

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Supreme Court mifepristone arguments center on docs' right to sue

Mass General Brigham physicians react to latest merger step

Scientific mystery highlights the blind spots in genomics databases

focus

focus

focus

Wikipedia